Analysis for PM
- 📈 Growth — 24/30
- 💰 Profitability — 18/20
- 🏦 Financial Health — 4/20
- 💵 Valuation — 6/20
- ⚠️ Risk — 8/10
Overall Score: 42/100
Summary:
📈 Growth & Financial Trajectory
Over eight quarters, PMI shows revenue growth from $8.79B (2024Q1) to $10.15B (2026Q1). Net income rose from about $2.14B to roughly $2.58B, with a mid-period peak near $3.61B in 2025Q3, finishing above the start level.
💰 Margins & Cash Flow
Gross margin stayed strong, averaging around 69% (range 65–74%), with operating margins near the high 30s percent. Cash flow from operations stayed positive across periods; 2026Q1 net cash from operating activities was about $0.58B, while investing cash flow was negative as capex and deals occurred.
🛡️ Balance Sheet & Liquidity
Balance sheet shows negative equity across quarters, signaling leverage. Assets about $66–69B vs. liabilities around $73–77B; current assets sit in the low-20s billions, suggesting modest liquidity headroom.
⚠️ Key Drivers & Risks
- Drivers: Pricing power in tobacco markets; ongoing cost containment and cash generation.
- Risks: Regulatory/liability exposure; high leverage with negative equity; currency and tax-rate sensitivity.